OTC Markets OTCQB - Delayed Quote USD

Renalytix Plc (RNLXY)

0.1900

-0.0070

(-3.55%)

At close: May 9 at 3:03:24 PM EDT

Renalytix plc Reports Financial Results for First Quarter of Fiscal Year 2025

Renalytix plc (LSE: RENX) (OTCQB: RNLXY), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care, reports its financial results for the fiscal quarter of 2025 ended September 30, 2024.

PR Newswire 5 months ago

RNLXY
-3.55%

RTNXF

Performance Overview

Return	RNLXY	FTSE 100 (^FTSE)
YTD	-6.86%	+4.67%
1-Year	-70.36%	+2.07%
3-Year	-96.01%	+18.54%